SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-24-000144
Filing Date
2024-12-20
Accepted
2024-12-20 17:28:55
Documents
15
Period of Report
2024-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20241217.htm   iXBRL 8-K 41979
2 EX-99.1 ex991pressrelease122024.htm EX-99.1 9516
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-24-000144.txt   190102

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20241217.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20241217_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20241217_pre.xml EX-101.PRE 13047
17 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20241217_htm.xml XML 2840
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 241569067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)